Idiopathic myelofibrosis.
Barosi G, Hoffman R.
Semin Hematol. 2005 Oct;42(4):248-58. doi: 10.1053/j.seminhematol.2005.05.018.
Idiopathic myelofibrosis: pathogenesis to treatment.
Reilly JT.
Hematol Oncol. 2006 Jun;24(2):56-63. doi: 10.1002/hon.771.
[Idiopathic myelofibrosis in internal medicine].
García-Gutiérrez V, Redondo S, Ruedas A.
Med Clin (Barc). 2014 Dec 9;143(11):498-501. doi: 10.1016/j.medcli.2014.05.034. Epub 2014 Aug 1.
Idiopathic myelofibrosis: a review.
Hasselbalch H.
Eur J Haematol. 1990 Aug;45(2):65-72. doi: 10.1111/j.1600-0609.1990.tb00419.x.
Idiopathic myelofibrosis: a clinical study of 80 patients.
Hasselbalch H.
Am J Hematol. 1990 Aug;34(4):291-300. doi: 10.1002/ajh.2830340411.
Idiopathic myelofibrosis: historical review, diagnosis and management.
Weinstein IM.
Blood Rev. 1991 Jun;5(2):98-104. doi: 10.1016/0268-960x(91)90041-a.
Chronic idiopathic myelofibrosis: clinicopathologic features, pathogenesis, and prognosis.
Ahmed A, Chang CC.
Arch Pathol Lab Med. 2006 Aug;130(8):1133-43. doi: 10.5858/2006-130-1133-CIM.
Biology and management of idiopathic myelofibrosis.
Smith BD, Moliterno AR.
Curr Opin Oncol. 2001 Mar;13(2):91-4. doi: 10.1097/00001622-200103000-00002.
Idiopathic myelofibrosis: pathogenesis, natural history and management.
Reilly JT.
Blood Rev. 1997 Dec;11(4):233-42. doi: 10.1016/s0268-960x(97)90022-9.
Hematopathologic findings in chronic idiopathic myelofibrosis.
Thiele J, Kvasnicka HM.
Semin Oncol. 2005 Aug;32(4):380-94. doi: 10.1053/j.seminoncol.2005.04.010.
